Impact of tumor position displacement during end-exhalation breath-hold condition on tumor dose in lung stereotactic body radiation therapy using volumetric modulated arc therapy by Tatsuya Kamima, Shunsuke Moriya, Takeji Sakae, Hikaru Miyauchi, Yasushi Ito, Kenji Tokumasu, Yasuo Yoshioka

“…Conclusion: Our study showed that tumor position displacements during breath-holding may lead to substantial tumor dose reduction.…”
Get full text

Orbital Tumors Excision without Bony Marginotomy under Local and General Anesthesia by Robert A. Goldberg, Daniel B. Rootman, Nariman Nassiri, David B. Samimi, Joseph M. Shadpour

“…All tumors were located in the posterior half of the orbit. …”
Get full text

Correlation of Dynamic PET and Gene Array Data in Patients with Gastrointestinal Stromal Tumors by Ludwig G. Strauss, Antonia Dimitrakopoulou-Strauss, Dirk Koczan, Leyun Pan, Peter Hohenberger

“…Gene array data were based on tumor specimen obtained by surgery after the PET examinations. …”
Get full text

The Search of miRNA Related to Invasive Growth of Nonfunctioning Gonadotropic Pituitary Tumors by Joanna Boresowicz, Paulina Kober, Natalia Rusetska, Maria Maksymowicz, Agnieszka Paziewska, Michalina Dąbrowska, Natalia Zeber-Lubecka, Jacek Kunicki, Wiesław Bonicki, Jerzy Ostrowski, Janusz A. Siedlecki, Mateusz Bujko

“…Nonfunctioning gonadotropic pituitary neuroendocrine tumors (PitNETs) are among the most frequent neoplasms of pituitary gland. …”
Get full text

Review on the Relationship between Human Polyomaviruses-Associated Tumors and Host Immune System by Serena Delbue, Manola Comar, Pasquale Ferrante

Get full text

Neoadjuvant Chemoradiotherapy Upregulates the Immunogenicity of Cold to Hot Tumors in Esophageal Cancer Patients by Yushi Nagaki, MD, PhD, Satoru Motoyama, MD, PhD, Yusuke Sato, MD, PhD, Akiyuki Wakita, MD, PhD, Hiromu Fujita, MD, PhD, Kohei Kemuriyama, MD, Ryohei Sasamori, MD, Shu Nozaki, MD, Kyoko Nomura, MD, PhD, Yoshihiro Minamiya, MD, PhD

“…Based on immunohistochemical analysis, tumors that were FOXA1 (+) and/or EYA2 (+) were defined as hot tumors, others were cold tumors. …”
Get full text

The Role of HLA-Class Ib Molecules in Immune-Related Diseases, Tumors, and Infections by Fabio Morandi, Enrico Fainardi, Roberta Rizzo, Nathalie Rouas-Freiss

Get full text

Dilemmas in Endoscopic Management of Rectal Neuroendocrine Tumors: A Case-Based Discussion by Brian P. Rajca, Mihir S. Wagh

“…Rectal neuroendocrine tumors are uncommon neoplasms that historically were regarded as having an indolent course. …”
Get full text

Transcriptome Concordance Between Borderline Tumors and Endometrioid Carcinoma: An Integrative Genomic Analysis by Mio Takahashi, Kohei Nakamura, Tatsuyuki Chiyoda, Chihiro Okada, Sachio Nohara, Reika Takamatsu, Shintaro Yanazume, Hiroaki Kobayashi, Hiroshi Nishihara, Wataru Yamagami

Subjects: “…borderline ovarian tumor…”
Get full text

Evaluation of Positron Emission Tomographic Tracers for Imaging of Papillomavirus-Induced Tumors in Rabbits by Sonja Probst, Stefan Wiehr, Frederic Mantlik, Holger Schmidt, Armin Kolb, Peter Münch, Maria Delcuratolo, Frank Stubenrauch, Bernd J. Pichler, Thomas Iftner

“…Increased tracer uptake was found 2 months postinfection in primary tumors with 18 F-FDG and 11 C-choline, whereas 18 F-FLT failed to detect the tumors at all measured time points. …”
Get full text

Targeting chromosomally unstable tumors with a selective KIF18A inhibitor by Aaron F. Phillips, Rumin Zhang, Mia Jaffe, Ryan Schulz, Marysol Chu Carty, Akanksha Verma, Tamar Y. Feinberg, Michael D. Arensman, Alan Chiu, Reka Letso, Nazario Bosco, Katelyn A. Queen, Allison R. Racela, Jason Stumpff, Celia Andreu-Agullo, Sarah E. Bettigole, Rafael S. Depetris, Scott Drutman, Shinsan M. Su, Derek A. Cogan, Christina H. Eng

“…To identify genes uniquely essential to chromosomally unstable cells, we mined the Cancer Dependency Map for genes essential in tumor cells with high levels of copy number aberrations. …”
Get full text

Differential Gene Expression in Primary Breast Tumors Associated with Lymph Node Metastasis by Rachel E. Ellsworth, Lori A. Field, Brad Love, Jennifer L. Kane, Jeffrey A. Hooke, Craig D. Shriver

“…Although ANOVA analysis (𝑃<.001, fold-change >1.5) revealed 13 differentially expressed genes, hierarchical clustering classified 90% of node-negative but only 66% of node-positive tumors correctly. The inability to derive molecular profiles of metastasis in primary tumors may reflect tumor heterogeneity, paucity of cells within the primary tumor with metastatic potential, influence of the microenvironment, or inherited host susceptibility to metastasis.…”
Get full text

HLA-DMB correlates with antitumor immunity and an improved prognosis in endometrial carcinoma tumors by Xiaoyu Xi, Xiaona Zhang, Jianxin Tang, Xiumei Fan, Jiexian Du

Subjects: Get full text

Development of a new nanobiotechnology method for the differential diagnosis of ocular adnexal tumors by S.V. Saakyan, D.A. Skladnev, A.P. Alekseeva, O.V. Beznos, V.V. Sorokin

“…Benign and malignant tumors are characterized by different metabolic activities, i.e., benign eyelid and conjunctival tumors reduce cations more slowly than malignant tumors. …”
Get full text

Stochastic modelling of PTEN regulation in brain tumors: A model for glioblastoma multiforme by Margherita Carletti, Matteo Montani, Valentina Meschini, Marzia Bianchi, Lucia Radici

Subjects: “…brain tumors…”
Get full text

Heterogeneity of Genetic Landscapes in Salivary Gland Tumors and Their Critical Roles in Current Management by Anam YOUSAF, Sarina SULONG, Baharudin ABDULLAH, Norhafiza Mat LAZIM

Subjects: “…salivary glands tumor…”
Get full text

A Potential Concept In The Management of Tumors With Modulation of Prostaglandin, Nitric Oxide and Antioxidants by Noori S. Al-Waili

“…This is supported by reports that demonstrate the immunosuppressive effects of PGs in tumors. PG inhibitors have also been shown to be crucial in the prevention of tumors such as esophageal and colon cancers. …”
Get full text

Catecholamine Secretory Tumors, Should Acute Lymphoblastic Leukemia be Included Under this Paradigm? by Antoine Fakhry AbdelMassih, Bann Khraisat, Christeen Sourial

Get full text

Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumors by Giorgia Anastasio, Michela Felaco, Alessia Lamolinara, Francesco del Pizzo, Elisa Cacciagrano, Carla Mottini, Margherita Mutarelli, Francesca Di Modugno, Manuela Iezzi, Luca Cardone

“…Inhibiting PARP with OLA further improves efficacy, even in BRCA1/2-wild-type and homologous recombination (HR)-proficient tumors but not in KRAS-independent tumors. The combination was especially effective in dKRAS-PDAC with a BRCA2 mutation, preventing metastasis growth. …”
Get full text

Promising markers of CIMP+ colon tumors identified on the basis of TCGA data analysis by G. S. Krasnov, A. D. Beniaminov, R. A. Tychko, G. A. Puzanov, R. O. Novakovskiy, A. V. Kudryavtseva, A. A. Dmitriev

“…CIMP+ (CpG­Island Methylator Phenotype) tumors are characterized by dense methylation of promoter CpG islands of many genes at once and represent a separate group of malignant neoplasms of the colon. …”
Get full text